NeuroMetrix, Inc.

medical devices

About

NeuroMetrix, Inc. is a healthcare technology company based in Waltham, Massachusetts, specializing in non-invasive medical devices for diagnosing and treating pain and neurological disorders. Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology, NeuroMetrix is publicly traded on NASDAQ under the ticker symbol NURO. The company offers two main products: Quell®, an FDA-authorized wearable neurostimulation device for chronic pain relief, and DPNCheck®, a point-of-care diagnostic device for detecting peripheral neuropathies. These products cater to healthcare providers, including neurologists and pain specialists, as well as patients seeking non-pharmacological treatment options. NeuroMetrix markets its products globally through a network of distributors across various regions. Following its acquisition by electroCore, Inc. in 2025, NeuroMetrix continues to operate under its established brand, focusing on advancing neurotechnology to improve health outcomes.

Technologies

Amazon SES Outlook Google Cloud Hosting Bluekai Drupal WP Engine Remote

Keywords

consumer health tech wearable devices medical devices neurotechnology digital health pain management biomedical engineering medical/dental instruments health care medical equipment manufacturing non-invasive medical devices medical equipment and supplies manufacturing healthcare equipment and supplies manufacturing high-power nerve stimulator automated nerve testing high-power nerve stimulation consumer health products smart therapy management neurological disorder diagnosis healthtech proprietary consumables personalized neurostimulation sleep and symptom monitoring medical device patents b2c neurostimulation microchip neurological diagnostics home use testing app-based therapy tracking

Location

4b Gill St, Woburn, Massachusetts, United States, 01801-1721

Related Companies

Companies in the same industry